상단메뉴 바로가기 본문 바로가기 본문 하위메뉴 바로가기 하단 바로가기

News

HOMENews

News

LyseNTech completed MTA and CDA with LegoChem Biosciences

관리자   /   2020-08-04

Aug 3, 2020 

 

LyseNTech completed MTA and CDA with LegoChem Biosciences and started a joint study to improve the function of endolysins.

 

LegoChem Biosciences is a biopharmaceutical company focusing on the development of next generation novel therapeutics utilizing its proprietary medicinal drug discovery technology LegoChemistry™.